构建疗法:设计下一波抗体和细胞免疫疗法
Stefanie R Bailey1, Eric Bartee2, Kyle G Daniels3
1Department of Pediatrics, University of Virginia, Charlottesville, Virginia, USA.
Journal for immunotherapy of cancer
|August 25, 2025
概括
新一代免疫瘤疗法正在开发中,以提高癌症治疗的有效性. 这些新的方法旨在增强免疫反应,克服当前治疗的局限性,以改善患者的治疗结果.
科学领域:
- 癌症学
- 免疫学
背景情况:
- 免疫瘤学通过利用免疫系统改变了癌症治疗.
- 目前的治疗方法如检查点抑制剂和T细胞疗法表现出成功,但有局限性,许多患者没有反应或复发.
研究的目的:
- 突出新兴的免疫瘤技术和加强免疫应对癌症的策略.
- 检查构造设计,临床转化和下一代免疫疗法的组合方法的进展.
主要方法:
- 对新型免疫瘤学构造的审查:双特异细胞疗法组合,装甲细胞,绑定细胞因子,免疫刺激抗体结合物和体内基因编辑.
- 对临床转换和组合方法的分析.
- 检查转化障碍和现实世界的挑战.
主要成果:
- 新兴技术正在设计以提高特异性,持久性和免疫激活.
- 创新工程有潜力创造更安全,更持久,更容易获得的免疫疗法.
结论:
- 克服当前免疫瘤学的局限性需要新的工程结构和组合策略.
- 研究人员,临床医生,行业和政策制定者之间的协调努力对于在全球范围内提供治愈癌症的免疫疗法至关重要.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
01:31Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
01:36Humoral Immune Responses
75.8K
Overview
75.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:24B Cell Activation and Differentiation
5.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
5.6K